AI finds new uses for old drugs at Every Cure
Every Cure is focused on finding ways to use existing medicines to treat diseases for which they weren’t initially intended or developed — aka “drug repurposing.”
Cofounded by a Penn prof battling his own rare disease, the nonprofit is building a biomedical knowledge graph using large language models to review medical literature and identify relationships between biomedical concepts. The graph will reflect connections between drugs and diseases to help as many patients as possible.
➡️ Read more about Every Cure’s mission here
30+ vendors strut their stuff for Philly biotech
The University City Science Center was packed to the brim last Wednesday with more than 30 major life sciences companies and organizations displaying new technologies and services at the second annual Life Science Vendor Showcase.
“With the biotech industry just blowing up, especially here in the Philadelphia area, it’s really important for us to be able to introduce ourselves to the new companies, the new people moving in,” Kristen Hightower, senior technical sales specialist for Thermo Fisher Scientific, told Technical.ly.
➡️ Read more about the vendors that attended the showcase here
News Incubator: What else to know today
• The Department of Justice filed its antitrust lawsuit against Apple — and instead of filing in DC or California, the suit was filed in New Jersey. We chatted with a law prof and found the likely reason why. [Technical.ly]
• Two Philly life sciences projects are among the 10 largest in the nation, according to a report from real estate agency Commercial Search: 3201 Cuthbert St., a Drexel-connected tower; and 3151 Market St., part of Schuylkill Yards, which is also a Drexel venture. [CommercialSearch/Drexel/Brandywine]
• DiverseForce graduated the 11th cohort of its On Boards program, which works to connect professionals of color with nonprofit boards. [YouTube]
• Self-administered injectable medications lead to more independence and more adherence to treatment plans. That’s the opinion of more than 90% of healthcare providers and patients in a survey from West Pharmaceuticals. [LinkedIn/Technical.ly]
🗓️ On the Calendar
Sarah Huffman is a 2022-2024 corps member for Report for America, an initiative of The Groundtruth Project that pairs young journalists with local newsrooms. This position is supported by the Lenfest Institute for Journalism.
Welcome to the daily roundup of the latest from Philly's tech and entrepreneurship scene. Want this in your inbox? Subscribe for free.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
